Latest Canurta Therapeutics News & Updates

See the latest news and media coverage for Canurta Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Canurta Therapeutics

AI-backed multi-target botanical therapies developer

canurta.com

Headquarters: Mississauga, Canada
Founded year: 2021
Company type: Private company
Number of employees: 15–50

Last updated Today

Latest news about Canurta Therapeutics

In short: Canurta Therapeutics advanced its botanical drug pipeline and secured a strategic investment from PharmaDrug Inc. for up to 40% equity ownership.

Company announcements

March 24 Canurta Therapeutics

Canurta builds AI platform for adaptive botanical therapies

The Polykye™ AI Platform accelerates discovery, optimization, and production of multi-target botanical drugs, enabling adaptive medicine.

March 2 Canurta Therapeutics

Canurta Therapeutics announces preclinical GBM study

Cannflavin B reduces tumor cell viability, migration, and invasion in vitro at low concentrations. Findings offer insights into cancer behavior.

February 26 Canurta Therapeutics

Canurta Therapeutics evaluates CNR-401 for dogs with DM

The clinical study, organized with Université de Montréal, targets dogs diagnosed with degenerative myelopathy due to SOD1 mutation. Contact the research team for eligibility.

February 17 Canurta Therapeutics

Canurta Therapeutics enters strategic partnership with extractX Ltd

The collaboration integrates Canurta's extraction methodologies into the enhanced Extract Mobile Lab Platform (EML 2.0), accelerating lab-to-commercial production.

Media coverage

January 5 Seeking Alpha

PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring

Toronto, Ontario--(Newsfile Corp. - January 5, 2026) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on...

30 October 2025 Yahoo Finance

PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc

Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on...

30 July 2025 The Globe and Mail

PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring

Toronto, Ontario--(Newsfile Corp. - January 5, 2026) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on...

23 February 2025 Yahoo Finance

Canurta Therapeutics to Present at the Life Sciences Investor Forum November 14th

MISSISSAUGA, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Canurta Therapeutics (a Canadian Private Controlled Company), based in Mississauga, Ontario, pioneering the development of novel botanical-drugs...

Never miss news about Canurta Therapeutics

Track Canurta Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.